There are many ongoing advances in the management of high risk and locally advanced prostate cancer, including concepts of systemic therapy intensification and de-escalation, dose escalation, and the use of biomarkers.
There are many evidence-based recommendations for nutrition and lifestyle in prostate cancer. Failure to counsel patients on nutrition and lifestyle leads to lower quality of care.
Radiopharmaceutical therapies have been a breakthrough cancer treatment for tumors resistant to cytotoxic chemotherapy and many new radiopharmaceutical agents are in active development.
Join us for a series of informal engagement sessions designed to provide a space for open discussions and collaboration around mentorship, sponsorship and career transitions. These 30-minute online sessions are open to all ASTRO members and members-in-training.
Facebook
X
LinkedIn
Forward
